We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Lawmakers who want to tackle sky-high drug prices are going to have lots of new ammunition, thanks to the new hospital drug pricing transparency rule from the Centers for Medicare and Medicaid Services (CMS) and the analyses that are now starting to appear because of it. Read More
Pfizer and BioNTech have struck a supply deal with the World Health Organization (WHO)-backed COVAX program, pledging to ship up to 40 million doses of their COVID-19 vaccine this year for an undisclosed price. Read More
Eli Lilly has agreed to pay Dutch drugmaker Merus up to $1.6 billion to develop novel T-cell re-directing bispecific antibodies for treating various cancers. Read More
A new survey has found that interactions between U.S. family medicine residencies and the pharma industry in 2019 continued a decade-long downward trend. Read More
Mylan and three pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRx — must face a class-action lawsuit claiming that the drugmaker paid bribes and kickbacks to the three companies to ensure a monopoly market for EpiPen, a federal judge has ruled. Read More
What would have been the biggest patent verdict in history will not be reinstated in favor of Merck, after the Supreme Court Tuesday declined to hear the pharma giant’s last appeal. Read More
The European Union (EU) and Canada will see temporary reductions in shipments of the Pfizer/BioNTech COVID-19 vaccine as Pfizer upgrades its Belgian facility to meet a goal of producing 2 billion doses annually, raising concerns as global coronavirus cases surge. Read More
Most of the 53 novel drugs approved by the FDA in 2020 were reviewed through at least one expedited approval process, the agency said in a report on the year. Read More
President-elect Joe Biden has committed to invoking the Defense Production Act to bolster the manufacturing of COVID-19 vaccines and supplies needed to administer shots, calling the Trump administration’s efforts to roll out vaccines “a dismal failure.” Read More
Billionaire and television personality Mark Cuban has unveiled the Mark Cuban Cost Plus Drug Company, which aims to produce low-cost versions of expensive generics. Read More